Human immunodeficiency virus-associated dementia: clinical aspects, biology, and treatment.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Handbook of Clinical Neurology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0072-9752(07)01269-9PMID 18631795
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HIV-associated cognitive impairment before and after the advent of combination therapy

  2011cited by this paper
• Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathways.

  2005cited by this paper
• Principles of Neurologic Infectious Diseases

  2004cited by this paper
• Novel markers of oxidative stress in actively progressive HIV dementia.

  2004cited by this paper
• Loss of neurons in the frontal cortex in AIDS brains

  2004cited by this paper
• Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

  2004cited by this paper
• Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.

  2004cited by this paper
• Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex.

  2004cited by this paper
• Human immunodeficiency virus-associated dementia: An evolving disease

  2003cited by this paper
• Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia

  2002cited by this paper
• Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis.

  2001cited by this paper
• Correlation between neurological progression and astrocyte apoptosis in HIV‐associated dementia

  2001cited by this paper
• Clinical and spectroscopic improvement in HIV-associated cognitive impairment

  2001cited by this paper
• Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women

  2001cited by this paper
• HIV in the brain

  2001cited by this paper
• Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain.

  2000cited by this paper
• HIV Infection and Dementia

  2000cited by this paper
• Cytotoxicity by matrix metalloprotease-1 in organotypic spinal cord and dissociated neuronal cultures.

  2000cited by this paper
• Transdermal selegiline in HIV-associated cognitive impairment: Pilot, placebo-controlled study

  2000cited by this paper
• Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors.

  2000cited by this paper
• Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia

  2000cited by this paper
• Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.

  1999cited by this paper
• Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team.

  1999cited by this paper
• Molecular Medicine © 1999 The Picower Institute Press Rate and Severity of HIV-Associated Dementia (HAD): Correlations with Gp4l and iNOS

  1999cited by this paper
• Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis.

  1999cited by this paper
• Transient Exposure to HIV-1 Tat Protein Results in Cytokine Production in Macrophages and Astrocytes

  1999cited by this paper
• Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment.

  1999cited by this paper
• Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia

  1999cited by this paper
• Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex

  1999cited by this paper
• Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function

  1998cited by this paper
• A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment

  1998cited by this paper
• Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia.

  1998cited by this paper
• Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after the initiation of protease inhibitor therapy.

  1998cited by this paper
• Matrix metalloproteinases and diseases of the CNS.

  1998cited by this paper
• Synaptic laminin prevents glial entry into the synaptic cleft

  1998cited by this paper
• Parkinsonism with HIV infection

  1998cited by this paper
• A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders.

  1998cited by this paper
• Unique monocyte subset in patients with AIDS dementia.

  1997cited by this paper
• Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage.

  1997cited by this paper
• Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry.

  1997cited by this paper
• Changing incidence of AIDS‐defining illnesses in the era of antiretroviral combination therapy

  1997cited by this paper
• Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain

  1997cited by this paper
• Perspectives Series : Cytokines and the Brain Cytokines in the Brain during Viral Infection : Clues to HIV-associated Dementia

  1997cited by this paper
• The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases.

  1997cited by this paper
• Localization of HIV‐1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry

  1996cited by this paper
• Neuronal pattern correlates with the severity of human immunodeficiency virus-associated dementia complex. Usefulness of spatial pattern analysis in clinicopathological studies.

  1996cited by this paper
• AIDS dementia complex and HIV‐1 brain infection: Clinical‐virological correlations

  1995cited by this paper
• HIV Dementia Scale: a rapid screening test.

  1995cited by this paper
• AIDS dementia complex: evaluation with proton MR spectroscopic imaging.

  1995cited by this paper
• Human immunodeficiency virus type 1 tat activates non—N‐methyl‐D‐aspartate excitatory amino acid receptors and causes neurotoxicity

  1995cited by this paper
• Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus.

  1993cited by this paper
• Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

  1993cited by this paper
• Human immunodeficiency virus type 1 infection of the nervous system: Pathogenetic mechanisms

  1993cited by this paper
• Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation

  1993cited by this paper
• Selective Neuronal Vulnerability in HIV Encephalitis

  1992cited by this paper
• Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains.

  1991cited by this paper
• The AIDS dementia complex.

  1988cited by this paper
• Neurologic Manifestations of AIDS

  1987cited by this paper
• The AIDS dementia complex: II. Neuropathology

  1986cited by this paper

• No citing papers are available for this paper.